RecruitingPhase 3NCT04659317
Opioid-Free Orthopaedics
A Double-Blinded Randomized Controlled Trial Examining Multimodal Opioid-Free Orthopaedic Procedures
Sponsor
Emory University
Enrollment
80 participants
Start Date
Dec 11, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this investigation is to compare effectiveness of this multimodal regimen at controlling postoperative pain with and without the use of opioid medications.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Any patient with advanced arthritis undergoing a total joint replacement (e.g. total shoulder arthroplasty, anatomic or reverse), in the primary setting.
- Any patient undergoing an orthopaedic procedure or surgery of their finger, hand, wrist, forearm, or elbow
- Any patient undergoing an orthopaedic procedure or surgery for their hip, knee, ankle or foot
- Patients who have exhausted 3+ months of nonoperative treatment to include activity modifications, optional corticosteroid injections, and physical therapy.
- Patients over the age of 18 years old that are willing to participate in the study and mentally capable to consent
Exclusion Criteria3
- Patients with concurrent and significant injuries to other bones or organs, local infections, history of alcohol or medical abuse, preoperative opioid use within 3 months of the surgery, advanced renal or liver disease, contraindication to receiving a nerve block, uncontrolled diabetes mellitus (HbA1C >9.0), or if a prior gastric ulcer precludes Aspirin and anti-inflammatory medications.i. Prior to inclusion, the patient will undergo blood testing to evaluate both kidney and liver function, including estimated glomerular filtration rate (GFR) as well as alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
- Workman's compensation status, minors, vulnerable subjects, women who are pregnant, or those who are not willing to consent to participate in the study.
- Patients who, in the opinion of the investigator, may be non-compliant with study schedules or procedures
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGOxycodone 5 mg Oral Tablet
Encapsulated Oxycodone 5 mg tablets x24, to take po q6 hours as needed
DRUGPlacebo oral tablet
Encapsulated placebo tablets x24, to take po q6 hours as need for pain
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04659317
Related Trials
Brain Circuitry Changes in Central Poststroke Pain: a Clinical and Neuroimaging Study
NCT053356681 location
Music Use in Parturients Admitted to Labor & Delivery
NCT069691051 location
Clinical and Scientific Assessment of Pain and Painful Disorders
NCT027070291 location
The Impact of Gender Affirming Hormone Therapy on Pain In Gender Minority Adults
NCT069392571 location
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
NCT057461431 location